Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
Arvind Ravi(Broad Institute), Justin F. Gainor(Harvard University), Chip Stewart(Broad Institute), Hira Rizvi(Memorial Sloan Kettering Cancer Center), Victor E. Velculescu(Johns Hopkins University), Roy S. Herbst(Smilow Cancer Hospital), Don L. Gibbons(The University of Texas MD Anderson Cancer Center), Marta Łuksza(Institute for Advanced Study), Aaron T. Griffin(Columbia University Irving Medical Center), Yo Akiyama(Broad Institute), Julie R. Brahmer(Johns Hopkins University), Monica Arniella(Broad Institute), Matthew D. Hellmann(AstraZeneca (United States)), Biagio Ricciuti(Harvard University), Kurt A. Schalper(Yale University), Andrea Califano(Columbia University Irving Medical Center), John V. Heymach(The University of Texas MD Anderson Cancer Center), Pasi A. Jänne(Harvard University), Nir Hacohen(Cambridge Hospital), Subba R. Digumarthy(Massachusetts General Hospital), Jedd D. Wolchok(Cornell University), Vashine Kamesan(Massachusetts General Hospital), Valsamo Anagnostou(Johns Hopkins University), Patrick M. Forde(Sidney Kimmel Comprehensive Cancer Center), Ignaty Leshchiner(Broad Institute), Samuel S. Freeman(Broad Institute), Benjamin D. Greenbaum(Memorial Sloan Kettering Cancer Center), Andrew Chow(Merck & Co., Inc., Rahway, NJ, USA (United States)), Vamsidhar Velcheti(Cleveland Clinic), Mark Holton(Broad Institute), Mari Mino–Kenudson(Massachusetts General Hospital), Naiyer A. Rizvi(Synthego (United States)), Brian S. Henick(NewYork–Presbyterian Hospital), Jaegil Kim(GlaxoSmithKline (United States)), Vivek Naranbhai(Centre for Human Genetics), Alice T. Shaw(Dana-Farber Cancer Institute), Jonathan W. Riess(Comprehensive Blood & Cancer Center), Mark M. Awad(Memorial Sloan Kettering Cancer Center), Mustafa Sakhi(Massachusetts General Hospital), Gad Getz(Broad Institute), Natalie I. Vokes(The University of Texas MD Anderson Cancer Center), Nathan A. Pennell(Cleveland Clinic)
Cited by 185
Related Papers
Full-length transcriptome assembly from RNA-Seq data without a reference genome
|Nature Biotechnology|2011|22.7k
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k